Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neidhart

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biochemistry|September 24, 1991
Mechanism of the reaction catalyzed by mandelate racemase. 2. Crystal structure of mandelate racemase at 2.5-A resolution: identification of the active site and possible catalytic residuesD J Neidhart, P L Howell, G A Petsko, et al.
The Journal of Biological Chemistry|July 5, 1988
Preliminary x-ray data on crystals of mandelate racemaseD J Neidhart, V M Powers, G L Kenyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemiaR Gucalp, P Ritch, P H Wiernik, et al.
Cancer Treatment Reports|June 1, 1987
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group StudyB L Tranum, D Dixon, J Quagliana, et al.
Biochemistry|January 25, 1994
The role of lysine 166 in the mechanism of mandelate racemase from Pseudomonas putida: mechanistic and crystallographic evidence for stereospecific alkylation by (R)-alpha-phenylglycidateJ A Landro, J A Gerlt, J W Kozarich, et al.
Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.
Science (New York, N.Y.)|August 3, 1990
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 proteaseJ Erickson, D J Neidhart, J VanDrie, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biochemistry|September 24, 1991
Mechanism of the reaction catalyzed by mandelate racemase. 2. Crystal structure of mandelate racemase at 2.5-A resolution: identification of the active site and possible catalytic residuesD J Neidhart, P L Howell, G A Petsko, et al.
The Journal of Biological Chemistry|July 5, 1988
Preliminary x-ray data on crystals of mandelate racemaseD J Neidhart, V M Powers, G L Kenyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemiaR Gucalp, P Ritch, P H Wiernik, et al.
Cancer Treatment Reports|June 1, 1987
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group StudyB L Tranum, D Dixon, J Quagliana, et al.
Biochemistry|January 25, 1994
The role of lysine 166 in the mechanism of mandelate racemase from Pseudomonas putida: mechanistic and crystallographic evidence for stereospecific alkylation by (R)-alpha-phenylglycidateJ A Landro, J A Gerlt, J W Kozarich, et al.
Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.
Science (New York, N.Y.)|August 3, 1990
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 proteaseJ Erickson, D J Neidhart, J VanDrie, et al.
Pageof 3